{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T21:41:50Z","timestamp":1791322910872,"version":"4.3.1"},"reference-count":39,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2005,3,1]],"date-time":"2005-03-01T00:00:00Z","timestamp":1109635200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Immunology Letters"],"published-print":{"date-parts":[[2005,3]]},"DOI":"10.1016\/j.imlet.2004.11.009","type":"journal-article","created":{"date-parts":[[2004,12,10]],"date-time":"2004-12-10T14:36:13Z","timestamp":1102689373000},"page":"181-188","source":"Crossref","is-referenced-by-count":153,"title":["Mucosal adjuvants and anti-infection and anti-immunopathology vaccines based on cholera toxin, cholera toxin B subunit and CpG DNA"],"prefix":"10.1016","volume":"97","author":[{"given":"Jan","family":"Holmgren","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jenni","family":"Adamsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabienne","family":"Anju\u00e8re","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Clemens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cecil","family":"Czerkinsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristina","family":"Eriksson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carl-Fredrik","family":"Flach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annie","family":"George-Chandy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali M.","family":"Harandi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Lebens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Lehner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marianne","family":"Lindblad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erik","family":"Nygren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sukanya","family":"Raghavan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joaquin","family":"Sanchez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Stanford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia-Bin","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ann-Mari","family":"Svennerholm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Tengvall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.imlet.2004.11.009_bib1","first-page":"97","article-title":"The mucosal immune system and prospects for anti-infectious and anti-inflammatory vaccines","volume":"3","author":"Czerkinsky","year":"1995","journal-title":"Immunologist"},{"key":"10.1016\/j.imlet.2004.11.009_bib2","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1111\/j.1600-065X.1999.tb01339.x","article-title":"Mucosal immunity and tolerance: relevance to vaccine development","volume":"170","author":"Czerkinsky","year":"1999","journal-title":"Immuno Rev"},{"key":"10.1016\/j.imlet.2004.11.009_bib3","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1385\/IR:28:3:265","article-title":"Oral tolerance","volume":"28","author":"Wu","year":"2003","journal-title":"Immunol Res"},{"key":"10.1016\/j.imlet.2004.11.009_bib4","unstructured":"Cholera vaccines, WHO position paper. In: Weekly epidemiological, record, vol. 76, Geneva, Switzerland: World Health Organization; 2001. p. 117\u2013124."},{"key":"10.1016\/j.imlet.2004.11.009_bib5","series-title":"New generation vaccines","first-page":"499","article-title":"Oral B subunit-killed whole cell cholera vaccine","author":"Holmgren","year":"2004"},{"key":"10.1016\/j.imlet.2004.11.009_bib6","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1016\/0264-410X(93)90039-Z","article-title":"Cholera toxin and cholera B subunit as oral-mucosal adjuvant and antigen vector system","volume":"11","author":"Holmgren","year":"1993","journal-title":"Vaccine"},{"key":"10.1016\/j.imlet.2004.11.009_bib7","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1586\/14760584.2.2.205","article-title":"Mucosal adjuvants and anti-infection and anti-immunopathology vaccines based on cholera toxin, cholera toxin B subunit and CpG DNA","volume":"2","author":"Holmgren","year":"2003","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.imlet.2004.11.009_bib8","doi-asserted-by":"crossref","first-page":"2534","DOI":"10.1016\/S0264-410X(00)00553-3","article-title":"Mucosal vaccines: nontoxic derivatives of LT and CT as mucosal adjuvants","volume":"19","author":"Pizza","year":"2001","journal-title":"Vaccine"},{"key":"10.1016\/j.imlet.2004.11.009_bib9","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1016\/S0264-410X(02)00532-7","article-title":"Maturation of human dendritic cells induced by the adjuvant toxin: role of cAMP on chemokine receptor expression","volume":"21","author":"Gagliardi","year":"2003","journal-title":"Vaccine"},{"key":"10.1016\/j.imlet.2004.11.009_bib10","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.1128\/IAI.71.4.1740-1747.2003","article-title":"Cholera toxin and its B subunit promote dendritic cell vaccination with different influence on Th1\/Th2 development","volume":"71","author":"Eriksson","year":"2003","journal-title":"Infect Immun"},{"key":"10.1016\/j.imlet.2004.11.009_bib11","doi-asserted-by":"crossref","first-page":"33369","DOI":"10.1074\/jbc.M112337200","article-title":"Detoxification of cholera toxin without removal of its immunoadjuvanticity by the addition of (STa-related) peptides to the catalytic subunit","volume":"277","author":"Sanchez","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1016\/j.imlet.2004.11.009_bib12","doi-asserted-by":"crossref","first-page":"2432","DOI":"10.4049\/jimmunol.162.4.2432","article-title":"Adjuvanticity of the cholera toxin A1-based gene fusion protein, CTA1-DD, is critically dependent on the ADP-ribosyltransferase and Ig-binding activity","volume":"162","author":"Agren","year":"1999","journal-title":"J Immunol"},{"key":"10.1016\/j.imlet.2004.11.009_bib13","doi-asserted-by":"crossref","first-page":"3398","DOI":"10.4049\/jimmunol.167.6.3398","article-title":"CTA1-DD-immune stimulating complexes: a novel, rationally designed combined mucosal vaccine adjuvant effective with nanogram doses of antigen","volume":"167","author":"Mowat","year":"2001","journal-title":"J Immunol"},{"key":"10.1016\/j.imlet.2004.11.009_bib14","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1002\/eji.200324368","article-title":"Coupling of antigen to cholera toxin for dendritic cell vaccination promotes the induction of MHC class I-restricted cytotoxic T cells and the rejection of a cognate antigen-expressing model tumour","volume":"34","author":"Eriksson","year":"2004","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.imlet.2004.11.009_bib15","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.clim.2004.03.001","article-title":"Vaccination with dendritic cells pulsed in vitro with tumor antigen conjugated to cholera toxin efficiently induces specific tumoricidal CD8+ cytotoxic lymphocytes dependant on cyclic AMP activation of dendritic cells","volume":"112","author":"Sun","year":"2004","journal-title":"Clin Immunol"},{"key":"10.1016\/j.imlet.2004.11.009_bib16","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1146\/annurev.immunol.20.100301.064842","article-title":"CpG motifs in bacterial DNA and their immune effects","volume":"20","author":"Krieg","year":"2002","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.imlet.2004.11.009_bib17","first-page":"62","article-title":"Interactions between bacterial CpG-DNA and TLR9 bridge innate and adaptive immunity","volume":"5","author":"Wagner","year":"2002","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.imlet.2004.11.009_bib18","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1128\/JVI.77.2.953-962.2003","article-title":"A protective role of locally administered immunostimulatory CpG oligodeoxynucleotide in a mouse model of genital herpes infection","volume":"77","author":"Harandi","year":"2003","journal-title":"J Virol"},{"key":"10.1016\/j.imlet.2004.11.009_bib19","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1126\/science.270.5243.1811","article-title":"Identification of RANTES, MIP-1 alpha, and MIP-1 beta as the major HIV-suppressive factors produced by CD8+ T cells","volume":"270","author":"Cocchi","year":"1995","journal-title":"Science"},{"key":"10.1016\/j.imlet.2004.11.009_bib20","doi-asserted-by":"crossref","first-page":"7014","DOI":"10.1128\/IAI.71.12.7014-7022.2003","article-title":"Orally administered CpG oligodeoxynucleotide induces production of CXC and CC chemokines in the gastric mucosa and suppresses bacterial colonization in a mouse model of Helicobacter pylori infection","volume":"71","author":"Raghavan","year":"2003","journal-title":"Infect Immune"},{"key":"10.1016\/j.imlet.2004.11.009_bib21","first-page":"15","article-title":"Enhancing vaccine with immune stimulatory CpG DNA","volume":"3","author":"Krieg","year":"2001","journal-title":"Curr Opin Mol Ther"},{"key":"10.1016\/j.imlet.2004.11.009_bib22","first-page":"141","article-title":"CpG DNA as a potent inducer of mucosal immunity: implications for immunoprophylaxis and immunotherapy of mucosal infections","volume":"5","author":"Harandi","year":"2004","journal-title":"Curr Opin Investig Drugs"},{"key":"10.1016\/j.imlet.2004.11.009_bib23","doi-asserted-by":"crossref","first-page":"10795","DOI":"10.1073\/pnas.91.23.10795","article-title":"Cholera toxin B subunit: an efficient transmucosal carrier-delivery system for induction of peripheral immunological tolerance","volume":"91","author":"Sun","year":"1994","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.imlet.2004.11.009_bib24","doi-asserted-by":"crossref","first-page":"7196","DOI":"10.1073\/pnas.93.14.7196","article-title":"Treatment of experimental autoimmune encephalomyelitis by feeding myelin basic protein conjugated to cholera toxin B subunit","volume":"93","author":"Sun","year":"1996","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.imlet.2004.11.009_bib25","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1093\/intimm\/12.10.1449","article-title":"Oral administration of cholera toxin B subunit conjugated to myelin basic protein protects against experimental autoimmune encephalomyelitis by inducing transforming growth factor-\u03b2-secreting cells and suppressing chemokine expression","volume":"12","author":"Sun","year":"2000","journal-title":"Int Immunol"},{"key":"10.1016\/j.imlet.2004.11.009_bib26","doi-asserted-by":"crossref","first-page":"4610","DOI":"10.1073\/pnas.94.9.4610","article-title":"A cholera toxoid-insulin conjugate as an oral vaccine against spontaneous autoimmune diabetes","volume":"94","author":"Bergerot","year":"1997","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.imlet.2004.11.009_bib27","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1038\/nbt1098-934","article-title":"A plant-based cholera toxin B subunit-insulin fusion protein protects against the development of autoimmune diabetes","volume":"16","author":"Arakawa","year":"1998","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.imlet.2004.11.009_bib28","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1002\/1529-0131(199908)42:8<1628::AID-ANR10>3.0.CO;2-T","article-title":"Treatment of experimental autoimmune arthritis by nasal administration of a type II collagen-cholera toxoid conjugate vaccine","volume":"42","author":"Tarkowski","year":"1999","journal-title":"Arthritis Rheumatism"},{"key":"10.1016\/j.imlet.2004.11.009_bib29","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1002\/immu.200390025","article-title":"Prevention of mucosally induced uveitis with a HSP60-derived peptide linked to cholera toxin B subunit","volume":"33","author":"Phipps","year":"2003","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.imlet.2004.11.009_bib30","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1006\/clim.2000.4927","article-title":"Enhanced immunological tolerance against allograft rejection by oral administration of allogeneic antigen linked to cholera toxin B subunit","volume":"97","author":"Sun","year":"2000","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.imlet.2004.11.009_bib31","first-page":"1835","article-title":"Conditions affecting enhanced corneal allograft survival by oral immunization","volume":"39","author":"Ma","year":"1998","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.imlet.2004.11.009_bib32","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/S0264-410X(96)00135-1","article-title":"Suppression of delayed-type hypersensitivity and IgE antibody responses to ovalbumin by intranasal administration of Escherichia coli heat-labile enterotoxin B subunit-conjugated ovalbumin","volume":"5","author":"Tamura","year":"1997","journal-title":"Vaccine"},{"key":"10.1016\/j.imlet.2004.11.009_bib33","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1046\/j.1365-2222.2000.00849.x","article-title":"Prolonged oral treatment with low doses of allergen conjugated to cholera toxin B subunit suppresses immonoglobulin E antibody responses in sensitized mice","volume":"30","author":"Rask","year":"2000","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.imlet.2004.11.009_bib34","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/978-1-4615-0685-0_37","article-title":"Adoptive transfer of mucosal T cells or dendritic cells from animals fed with cholera toxin B subunit alloantigen conjugate induces allogeneic T cell tolerance","volume":"495","author":"Li","year":"2001","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.imlet.2004.11.009_bib35","doi-asserted-by":"crossref","first-page":"3522","DOI":"10.4049\/jimmunol.166.5.3522","article-title":"Oral administration of recombinant cholera toxin subunit B inhibits IL-12-mediated murine experimental (trinitrobenzene sulfonic acid) colitis","volume":"166","author":"Boirivant","year":"2001","journal-title":"J Immunol"},{"key":"10.1016\/j.imlet.2004.11.009_bib36","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1002\/(SICI)1521-4141(199802)28:02<424::AID-IMMU424>3.0.CO;2-U","article-title":"Selective tolerization of Th1-like cells after nasal administration of a cholera toxoid-LACK conjugate","volume":"28","author":"McSorley","year":"1998","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.imlet.2004.11.009_bib37","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.4049\/jimmunol.163.2.1045","article-title":"Intranasal administration of a Schistosoma mansoni glutathione S-transferase-cholera toxoid conjugate vaccine evokes antiparasitic and antipathological immunity in mice","volume":"163","author":"Sun","year":"1999","journal-title":"J Immunol"},{"key":"10.1016\/j.imlet.2004.11.009_bib38","first-page":"1","article-title":"A mucosally administered recombinant fusion protein vaccine against schistosomiasis protecting against immunopathology and infection","volume":"3435","author":"Lebens","year":"2001","journal-title":"Vaccine"},{"key":"10.1016\/j.imlet.2004.11.009_bib39","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1111\/j.1365-2249.2004.02520.x","article-title":"Oral tolerization with peptide 336\u2013351 linked to cholera toxin B subunit preventing relapses of uveitis in Behcet's disease","volume":"137","author":"Stanford","year":"2004","journal-title":"Clin Exp Immunol"}],"container-title":["Immunology Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016524780400313X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016524780400313X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,4,30]],"date-time":"2023-04-30T20:38:33Z","timestamp":1682887113000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S016524780400313X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,3]]},"references-count":39,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2005,3]]}},"alternative-id":["S016524780400313X"],"URL":"https:\/\/doi.org\/10.1016\/j.imlet.2004.11.009","relation":{},"ISSN":["0165-2478"],"issn-type":[{"value":"0165-2478","type":"print"}],"subject":[],"published":{"date-parts":[[2005,3]]}}}